The TOGETHER trials were initiated in June 2020 (archives),with the Bill & Melinda Gates Foundation provided seed funding. By September 21, 2020 Cytel had designed the “novel platform” to coordinate the COVID-19 TOGETHER clinical trials looking at outpatient treatments. As of September 2020 “
The protocol published in October 2020 stated “An Adaptive Randomized Platform Trial to Investigate the Efficacy of Novel Agents for Treatment of SARS-CoV-2 Infection Among High-Risk Outpatient Adults in Low and Middle Income Countries”, which was to be conducted in Brazil and South Africa. [1] Initially looking at four different treatments against a “placebo” of vitamin C [5, 6] (which should itself be a treatment!)!
The Brazilian clinical trials were sponsored by cardiovascular “card” research, and started January 27, 2021. [9]
Protocol versions – HERE
Trial publications – HERE
The Cytel “platform” approach is designed to find effective treatments quickly but also to “eliminate ” – as they did for hydroxychloroquine and ivermectin etc.
Cytel designed the trial tracking software [3], and the trials were
Dr Kory speaks to the shenanigans of the TOGETHER trial on ivermectin – WATCH